+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
MEDICAPS

MediCaps Share Price

 

 

MediCaps live price: ₹26.78. It opened at ₹27 vs previous close ₹27; intraday high/low: ₹28/₹26. The 50 & 200 DMA stand at ₹27.42/₹30.65.

MediCaps Performance

  • Today's Low
  • ₹26
  • Today's High
  • ₹28
  • 52 Week Low
  • ₹21
  • 52 Week High
  • ₹47
  • Open Price₹27
  • Previous Close₹27
  • Volume616
  • 50 DMA₹27.42
  • 100 DMA₹28.05
  • 200 DMA₹30.65

MediCaps Chart

Investment Returns

  • Over 1 Month -0.52%
  • Over 3 Month -1.47%
  • Over 6 Month -18.85%
  • Over 1 Year -39.18%

Smart Investing Starts Here Start SIP with MediCaps for Steady Growth!

Invest Now

MediCaps Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -11
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 33
  • P/B Ratio
  • 0.3
  • Average True Range
  • 1.94
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.39
  • RSI
  • 46.89
  • MFI
  • 32.26

MediCaps Financials

MediCaps Technicals

EMA & SMA

Current Price
₹26.78
+ 0.14 (0.53%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹27.00
  • 50 Day
  • ₹27.40
  • 100 Day
  • ₹28.00
  • 200 Day
  • ₹30.60

Resistance and Support

27.1 Pivot Speed
  • R3 29.95
  • R2 29.15
  • R1 27.90
  • S1 25.85
  • S2 25.05
  • S3 23.80

MediCaps Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-21 Audited Results
2026-02-11 Quarterly Results
2025-11-12 Quarterly Results
2025-08-05 Quarterly Results
2025-05-21 Audited Results

MediCaps Shareholding Pattern

No data available.

MediCaps FAQs

MediCaps share price is ₹26 As on 15 July, 2026 | 16:43

The Market Cap of MediCaps is ₹33.4 Cr As on 15 July, 2026 | 16:43

The P/E ratio of MediCaps is -11 As on 15 July, 2026 | 16:43

The PB ratio of MediCaps is 0.3 As on 15 July, 2026 | 16:43

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23